OBESITY AND ANTIVIRAL OUTCOMES: IS NIRMATRELVIR–RITONAVIR EFFECTIVE IN REDUCING HOSPITALIZATION IN OBESE PATIENTS WITH COVID-19?
OBESITY AND ANTIVIRAL OUTCOMES: IS NIRMATRELVIR–RITONAVIR EFFECTIVE IN REDUCING HOSPITALIZATION IN OBESE PATIENTS WITH COVID-19?Bruna Gomes Noronha, MD¹; Bruna Letícia de Oliveira²; Victor Barros Maciel do Amaral³; Antonio Rego Clemente de Jesus, MD⁴;
Authors
- Brian Noronha (ORCID: https://orcid.org/0009-0004-5981-3732)
- B. Oliveira (ORCID: https://orcid.org/0000-0001-9852-3333)
- A.P. Jesus (ORCID: https://orcid.org/0000-0003-4938-0000)
- Ana Carolina Toguchi (ORCID: https://orcid.org/0000-0002-0830-3490)
- Bruna Menezes (ORCID: https://orcid.org/0000-0002-8173-1125)
- Victor Barros Maciel do Amaral (ORCID: https://orcid.org/0000-0002-9119-073X)
- Victor Alejandro Gomez Galeano
Institutions
- Universidade Federal da Paraíba (BR)
- Universidade de Caxias do Sul (BR)
- Centro Universitário Católico Salesiano Auxilium (BR)
- Prefeitura Municipal de Esteio (BR)
- Auxilio Mutuo Hospital (PR)
- Centro Universitário São Camilo (BR)
- Universidade Federal do Estado do Rio de Janeiro (BR)
Publication Details
- Published
- 2025-08-18
- DOI
- https://doi.org/10.22541/au.175549326.63612338/v1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00